Abstract
In the mammalian liver, 60% of the cells are hepatocytes while the remainder (35%) include biliary epithelium, Kupffer cells, endothelial cells, fat storing cells and connective tissue cells. Although, neoplasms of hepatocytes are the most common liver tumors in humans, a significant number of other neoplasms including tumors of bile duct epithelium can develop. Not too long ago, liver tumors were left untreated because liver was considered as a complex and mysterious organ inaccessible to surgery. Advances in imaging procedures and surgical techniques over the past 30 years have revolutionized the approaches to the treatment of benign and malignant liver tumors. Subsegmentectomy, segmentectomy, lobectomy and transplantation are routinely performed for treatment of primary and metastatic liver tumors with minimal morbidity and mortality rates. Since accurate diagnosis remains the key to sound management, the emphasis of this article is on classification, morphological features and differential diagnosis of malignant neoplasms of liver.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Okuda K: Hepatocellular carcinoma. J Hepatol 32(Suppl 1): 225–237, 2000.
Okuda K, Peters RL and Simson IW: Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer 54:2165–2173, 1984.
Ng IOL, Lai ECS, Ng MMT and Fan ST: Tumor encapsulation in hepatocellular carcinoma. Cancer 70:45–49, 1992.
Kojiro M and Nakashima O: Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Sem Liver Dis 29:287–296, 1999.
Fernandez-Izquierdo A and Llombart-Bosch A: Immunohistochemical characterization of 130 cases of primary hepatic carcinomas. Path Res Pract 182: 783–191, 1987.
Ganjei P, Nadji M, Albores-Saavedia J, Morales AR: Histologic markers in primary and metastatic tumors of the liver. Cancer 62L 1996–1998, 1998.
Derrico A, Baccarini P, Florentino M, Ceccarelli C, Bonanzzi C, Ponzetto A, Sccazec JY, Mancini AM and Grigioni WF: Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. Hum Path 27:599–604, 1996.
Edmondson HA and Steiner PE: Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503, 1954.
Kondo F, Firooka N, Wada K and Kondo Y: Morphological clues for the diagnosis of small hepatocellular carcinoma. Virch Arch 411:15–21, 1987.
Okuda K, Nakashima T, Obata H and Kubo Y: Clinicopathological studies of minute hepatocellular carcinoma: Analysis of 20 cases including 4 with resection. Gastroenterology 73:109–115, 1977.
Farber E and Sarma DSR: Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 56:4–22, 1987.
Theise ND: Macroregenerative (dysplastic) nodules and hepatocarcinogenesis theoretical and clinical considerations. Sem Liver Dis 15:360–371, 1995.
Hytiroglou P, Theise ND, Schwartz M, Mor E, Miller C and Thung SN: Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology 21:703–708, 1995.
Okuda K and Nishioka M: Review of the Japanese literature. Cur Hepatology 17:315–337, 1997.
Craig JR, Peters RL, Edmondson HA and Omata M: Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clincopathologic features. Cancer 46:372–379, 1980.
Berman MM, Libbey NP and Foster JH: Hepatocellular carcinoma, polygonal cell type with fibrous stroma- an atypical variant with a favourable prognosis. Cancer 46:1448–1455, 1980.
Fachi DC, Shikes RH and Silverberg SA: Ultrastructure of fibrolamellar oncocytic hepatoma. Cancer 50:702–709, 1982.
Lefkowitch JH, Muschel R, Price JB, Manbou C and Braunhut S: Copper and Copper-binding protein in fibrolammelar liver cell carcinoma. Cancer 51:97–100, 1983.
Berman MA, Burnham JA, Shehan DU: Fibrolamellar carcinoma of the liver: an immunohistochemical study of nineteen cases and a review of the literature. Hum Pathol 19:784–794, 1988.
Payne CM, Nagle RB, Paplanus SH and Graham AR: Fibrolamellar carcinoma of liver: a primary malignant oncocytic carcinoid? Ultrastruct Pathol 10:539–552, 1986.
Maeda T, Adachi E, Kajiyama K, Takenaka K, Sugimachi K and Tsuneyoshi M: Spindle cell hepatocellular carcinoma. A clinicopathologic and immunohistochemical analysis of 15 cases. Cancer 77:51–57, 1996.
Ishak KG, Anthony PP and Sobin LH: Histological typing of tumors of the liver. 2nd Ed. Geneva: World Health Organization, 1994.
Haratake J and Horie A: An immunohistochemical study of sarcomatoid liver carcinomas. Cancer 68:93–97, 1991.
Zanconati F, Falconieri A, Lamovec JL and Zidar A: Small cell carcinoma of the liver: a hitherto unreported variant of hepatocellular carcinoma. Histopathol 29:449–453, 1996.
Omata M, Peters RL and Tatter D: Sclerosing hepatic carcinoma: relationship to hypercalcemia. Liver 1:33–49, 1981.
Okuda K and Okuda H: Primary liver cell carcinoma. In: Oxford text book of clinical hepatology, Ed: Bircher J, Benhamon J, Mcintyre N, Rizzetto M and Rodes J. Oxford Medical Publication, Vol 2, pp 1491–1530,1999.
Munoz PA, Rao MS and Reddy JK: Osteoclastoma-like giant cell tumor of the liver. Cancer 46:771–779, 1980.
Kuwano H, Sonada T, Hashimoto H and Enjoji M: Hepatocellular carcinoma with osteoclast-like giant cells. Cancer 54:837–842,1984.
Hood DL, Bauer TW, Leibel SA and Recmahon JT: Hepatic giant cell carcinoma: an ultrastructural and immunohistochemical study. Am J Clin Path 93:111–116,1990.
Stocker JT: Hepatoblastoma. Sem Diag Pathol 1994.
Reynolds M: Pediatric liver tumors. Sem Surg Oncol 16:159–172,1999.
Klatskin A and Conn HO: Neoplasms of the liver and intrahepatic bile ducts. In Histopathology of the liver, Oxford University Press, Oxford Vol 1, pp 367–395,1993.
Altman HW: Epithelial and mixed hepatoblastoma in the adult. Histological observations and general considerations. Path Res Pract 188:16–22,1988.
Ruck P, Xiao JC and Kaiseling E: Small epithelial cells and histogenesis of hepatoblastoma. Electron-microscopic, immuno-electronmiroscopic and immunohistochemical findings. Am J Pathol 148:321,1996.
Tsao M and Grisham JW: Hepatocarcinomas, cholangiocarcinomas and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells. A light and electron-microscopic analysis. Am J Pathol 127:168–181,1987.
Lack EE, Neave C and Vawter GF: Hepatoblastoma, a clinical and pathologic study of 54 cases. Am J Surg Pathol 6:693–705,1982.
Gonzalez-Crussi F, Upton MP and Maurer HS: Hepatoblastoma: attempt at characterization of histologic subtypes. Am J Surg Pathol 6:599,1982.
Nakajima T, Kondo Y, Miyazaki M and Okai K: A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and modes of spreading. Hum Pathol 19:1228–1234, 1988.
Yeo CT, Pitt HA and Cameron JL: Cholangiocarcinoma. Surg Clin North Am 70:1429–1447,1990.
Ho Y, Kojiro M, Nakashima Ta and Mori T: Pathomorphologic characteristics of 102 cases of thorotrast-related hepatocellular carcinoma, cholangiocarcinoma and hepatic angiosarcoma. Cancer 62:1153–1162,1998.
Schwartz DA: Cholangiocarcinoma associated with liver fluke infection: a preventable source of morbidity in Asian immigrants. Am J Gastroenterol 81:76–79,1986.
Colombani R and Tsui WMS: Biliary tumors of the liver. Sm Liver Dis 15:402–413,1995.
Rullier A, Le Baid B, Fawaz R, Blanc J, Sanic J and Bioulac-Sage P: Cytokeratin 7 and 20 expression in cholangiocarcinoma varies along the biliary tract but still differs from that in colorectal carcinoma metastatsis. Am J Surg Pathol 24:870–876,2000.
D’errico A, Baccarini P, Florentino M, Ceccarelli C, Bonazzi C, Ponzetto A, Scoazec JY, Mancini AY and Grigioni WF: Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA. Hum Pathol 27:599–604,1996.
Jalanko H, Kunsela P, Roberts S, Sippone P, Haghung F and Makela O: Comparison of a new marker CA-19–9T, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal disease. J Clin Pathol 37:218–222,1984.
Rivaney K, Goodman ZD and Ishak KG: Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 18:1078–1091,1994.
Kim YI, Kim ST, Lei AK and Choi BI: Papillary cystic tumor of the liver. A case report with ultrastructural observation. Cancer 65:2740–2746,1990.
Klimstra DS, Wenig BM and Hefess CS: Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Sem Dia Path 17:66–80,2000.
Ng IO, Shek TW, Nicholls J and Rea LT: Combined hepatocellularcholangiocarcinoma: a clinicopathologic study. J Gastroenterol Hepatol 13:34,1998.
Kondo Y and Wakajima T: Psuedoglandular hepatocellular carcinoma. A morphologic study. Cancer 60:1032–1037,1987.
Fischer HP, Doppl W, Osborn M and Altmannsbuger M:Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type. Virch Arch 56:71–76,1988.
Ishak KA, Sesterhenn IA, Goodman ZD, Rabin L and Stromeyer FW: Epitheloid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol 25:839–852,1984.
Dean PJ, Haggitt RC and O’hara CJ: Malignant epithelioid hemangioendothelioma of the liver in young women. Relationship to oral contraceptive use. Am J Surg Pathol 9:695–704,1989.
Kelleher MB, Inatsuki S and Sheahau DG: Epithelioid hemangioendothelioma of liver. Histopathology 13:999–1008,1989.
Popper H, Thomas LB, Teller NC, Flak H and Selikoff IJ: Development of hepatic angiosarcoma induced by vinyl chloride, thorotrast and arsenic. Comparison with cases of unkown etiology. Am J Pathol 92:349–376,1978.
Stocker JT and Ishak KG: Undifferentiated (embryonal) sarcoma of the liver. Report of 31 cases. Cancer 42:336–348,1978.
Anthony PP: Tumors and tumor-like lesions of the liver and biliary tract. In: Pathology of the liver, Eds: MacSween RMM, Anthony PP, Scheuer PJ, 2nd Edition, Churchhil Livingstone, Edinburgh, pp 574–665,1987.
Cody B: Natural history of primary and secondary tumors of the liver. Sem Oncology 10:127–134,1983.
Kawamoto K, Onodera H, Kan S and Imamuar M: Possible paracrine mechanism of insulin-like growth factor-2 in the development of liver metastases from colorectal carcinoma. Cancer 85:18–25,1999.
Sussman JJ and Ellis LM: Current therapy for hepatic mutations. Cur Hepatol 17:195–215,1997.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Wu, M.LC., Okonkwo, A.M., Jeruss, J.S., Rao, M.S. (2001). Pathologic Features of Primary and Metastatic Hepatic Malignancies. In: Talamonti, M.S., Pappas, S.G. (eds) Liver-Directed Therapy for Primary and Metastatic Liver Tumors. Cancer Treatment and Research, vol 109. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3371-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3371-6_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-3373-0
Online ISBN: 978-1-4757-3371-6
eBook Packages: Springer Book Archive